‘There is no alternative’ — stocks’ long-running ‘TINA’ advantage could be ending, worrying traders

Trader Talk

The New York Stock Exchange (NYSE) stands in the Financial District in Manhattan on January 28, 2021 in New York City.

Spencer Platt | Getty Images

Will March be the death of the “TINA” trade?

February started with the reflation trade, and ended with a bond market rout that scrambled stock valuations and caused some to wonder whether this is the end to the fabled “there is no alternative” to stocks notion.

The reflation trade:  Will it last?

With the S&P 500 up 2% in February, the sector outperformers are all associated with the reflation trade —sectors that benefit from the reopening of the U.S. and global economy.

Reflation trade in February

  • Energy up 24%
  • Banks up 19%
  • Industrials up 8%
  • Materials up 5%

At the same time, defensive sectors that are not considered cyclical in nature have lagged the markets.

Defensive sectors in February

  • Consumer Staples were flat
  • Health Care down 2%
  • Utilities down 5%

The end of TINA?

The narrative behind the reflation trade is still intact:  the vaccination pace is accelerating, the reopening of the U.S. economy is gaining steam, “go big” stimulus is coming, and 2021 earnings estimates have started rising.

But there is a new cloud on the horizon: higher bond yields are putting a lid on high-valuation stocks.

“There is no alternative to stocks,” (TINA) has become a mantra of bulls, arguing that yields have been so low that bonds were hardly worth owning as an asset class. 

That may now be changing, Savita Subramanian at Bank of America says:  “Income investors that were forced into equities for scarce yield may be more likely to move back to traditional fixed income assets and history suggests 1.75% (house forecast) on the 10-yr is the tipping point at which asset allocators begin to shift back into bonds.”

Which stocks get hurt when rates rise?

Not surprisingly, Subramanian says the sector that does best when rates start rising are financials. The sectors that tend to do worse are defensive: consumer staples, health care, utilities, and real estate.

That is exactly how the market is reacting. As rates rose in February, banks gained, and defensive stocks declined.

Another group that has been getting hurt on rising rates is technology stocks, and with good reason, Subramanian notes: “Ultra-low rates have ballooned valuations for secular growth stocks since the financial crisis,” she says. 

Not surprisingly, megacap tech stocks began moving down as soon as rates started rising.

Megacap tech in February

  • Apple down 8%
  • Xilinx down 4%
  • AMD down 4%
  • Facebook down 4%
  • Microsoft down 1%

The three factors that drive stock prices

The Federal Reserve has been furiously pumping money into the economy, and much of that money has found its way into the stock market and has been a major factor in why equities have done so well in the last year.

While “liquidity” (how much money is available to buy and sell stocks) is an important factor, stocks have traditionally risen on some combination of: 

  1. An increase in dividends;
  2. An increase in earnings; or
  3. An expansion of the P/E multiple. 

Vanguard founder Jack Bogle used to call dividends and earnings the “fundamental” part of stock investing, while calling stock rises based on expanding P/E ratios the “speculative” part of the market, that is, it represented investors betting on whether earnings might be rising in the future.

Much of the recent expansion in stock prices has been driven by an expansion of the P/E multiple, which now sits at roughly 22 times 2021 earnings. 

Big-cap technology stocks in particular saw dramatic rises in P/E multiples in 2020.  Chip maker Xilinx, for example, went from 25 to 50 times forward earnings.  NVIDIA went from 30 to 60.  Even old-school big cap tech stocks saw big moves up in their P/E levels last year with Microsoft going from 25 to 35, and Apple leaping from 20 to 35.

These multiples have dropped as interest rates have risen in 2021.

The bad news is that even if bond yields don’t move higher, the current move up appears to be putting a ceiling on valuations. 

If rates keep moving up, can stocks still go higher?

If higher rates are indeed putting a ceiling on stock multiples, than investors will have to rely on dividend increases and genuinely rising earnings (not just expectations) to propel prices forward.

Fortunately, there is good evidence this is happening. Analysts have consistently underestimated the strength of the economic recovery. Earnings estimates for the S&P 500 for the first quarter of 2021 have risen from 16.0% to 21.6% from January 1st to February 26th and second quarter earnings estimates have also risen, from 45.7 to 50.9% in the same period.

With rates unsettled, expect a volatile March

It’s a two-way battle between the bulls who say the markets can handle higher rates and those who say valuations are still too high, and between those who say the Fed is in danger of losing control of the low interest rate narrative.

Jim Paulsen from Leuthold has been a consistent bull on the rates vs. stocks debate.  “As [Fed Chair Jerome] Powell just said, a primary reason that bond yields are rising is because ‘real economic growth’ (and EPS) is recovering smartly,” he told me in an email.  “Is a 40-basis point rise in the real yield really that worrisome given the surge recently in 2021 EPS estimates almost back to all-time record highs?”

Looming over every investor is the Federal Reserve. Many believe the Fed will likely come under pressure to taper its bond purchases toward the end of this year.

That would put a further lid on stock prices, but the manner in which it is handled could spell the difference between moving sideways, and a major drop in the markets.

“If the market begins to believe that the Fed lost control, and the Fed senses that, there’s a chance that the Fed will overreact, so we’re in a very potentially volatile period,” Art Cashin from UBS said on our air.

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.

Articles You May Like

Nvidia’s stunning 2024 return has all the makings of a stock-market dynasty
Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbook
Dental supply stock rallies on theory RFK’s anti-fluoride stance will prompt more dentist visits
Activist ValueAct is poised to trim fat and help boost profits at Meta Platforms. Here’s how
Top Wall Street analysts are upbeat on these stocks for the long haul